Common Stock, Shares, Outstanding of Emergent BioSolutions Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Emergent BioSolutions Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Emergent BioSolutions Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 52,100,000, a 4.1% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Emergent BioSolutions Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 52,100,000 -2,200,000 -4.1% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 52,700,000 -1,400,000 -2.6% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 53,700,000 +800,000 +1.5% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 54,500,000 +2,100,000 +4% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 54,300,000 +2,100,000 +4% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 54,100,000 +2,300,000 +4.4% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 52,900,000 +1,100,000 +2.1% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 52,400,000 +2,000,000 +4% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 52,200,000 +2,100,000 +4.2% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 51,800,000 +1,900,000 +3.8% 30 Sep 2023 10-Q 11 Dec 2023 2023 Q3
Q2 2023 51,800,000 +1,900,000 +3.8% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 50,400,000 0 0% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 50,100,000 -1,200,000 -2.3% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 49,900,000 -3,800,000 -7.1% 30 Sep 2022 10-Q 11 Dec 2023 2023 Q3
Q2 2022 49,900,000 -3,800,000 -7.1% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 50,400,000 -3,200,000 -6% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 51,300,000 -1,800,000 -3.4% 31 Dec 2021 10-K/A 11 Dec 2023 2022 FY
Q3 2021 53,700,000 +700,000 +1.3% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 53,700,000 +800,000 +1.5% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 53,600,000 +1,300,000 +2.5% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 53,100,000 +1,400,000 +2.7% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 53,000,000 +1,400,000 +2.7% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 52,900,000 +1,300,000 +2.5% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 52,300,000 +900,000 +1.8% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 51,700,000 +500,000 +0.98% 31 Dec 2019 10-K 19 Feb 2021 2020 FY
Q3 2019 51,600,000 +1,413,701 +2.8% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 51,600,000 +1,585,472 +3.2% 30 Jun 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 51,400,000 +1,591,308 +3.2% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 51,200,000 +1,800,000 +3.6% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 50,186,299 +8,803,870 +21% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 50,014,528 +8,907,463 +22% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 49,808,692 +8,854,077 +22% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 49,400,000 +8,825,940 +22% 31 Dec 2017 10-K 22 Feb 2019 2018 FY
Q3 2017 41,382,429 +894,780 +2.2% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 41,107,065 +677,384 +1.7% 30 Jun 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 40,954,615 +1,120,204 +2.8% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 40,574,060 +1,167,482 +3% 31 Dec 2016 10-K 23 Feb 2018 2017 FY
Q3 2016 40,487,649 +1,602,569 +4.1% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 40,429,681 +1,687,071 +4.4% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 39,834,411 +1,509,064 +3.9% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 39,406,578 +1,696,895 +4.5% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 38,885,080 +1,337,056 +3.6% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 38,742,610 +1,270,336 +3.4% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 38,325,347 +1,019,147 +2.7% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 37,709,683 +1,085,640 +3% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 37,548,024 +1,236,883 +3.4% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 37,472,274 +1,285,511 +3.6% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 37,306,200 +1,188,347 +3.3% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 36,624,043 +754,651 +2.1% 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q3 2013 36,311,141 +171,204 +0.47% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 36,186,763 -17,154 -0.05% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 36,117,853 -42,309 -0.12% 31 Mar 2013 10-Q 03 May 2013 2013 Q1
Q4 2012 35,869,392 -133,306 -0.37% 31 Dec 2012 10-K 10 Mar 2014 2013 FY
Q3 2012 36,139,937 +270,912 +0.76% 30 Sep 2012 10-Q 01 Nov 2012 2012 Q3
Q2 2012 36,203,917 +353,259 +0.98% 30 Jun 2012 10-Q 03 Aug 2012 2012 Q2
Q1 2012 36,160,162 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 36,002,698 +991,275 +2.8% 31 Dec 2011 10-K 08 Mar 2013 2012 FY
Q3 2011 35,869,025 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 35,850,658 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q4 2010 35,011,423 31 Dec 2010 10-K 09 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.